Cognitive impairment, Constipation, Delusions, Dementia, Depression, Diplopia, Dysarthria, Dyskinesia, Dysphagia, Dystonia, Fluctuations in consciousness, Frequent falls, Gait disturbance, Gliosis, Hallucinations, Hyperreflexia, Hypomimic face, Hyposmia, Impulsivity, Intention tremor, Lewy bodies, Low frustration tolerance, Lower limb spasticity, Mask-like facies, Mental deterioration, Micrographia, Monotonic speech, Muscle spasm, Myoclonus, Neurogenic bladder, Neuronal loss in central nervous system, Orthostatic hypotension, Orthostatic hypotension due to autonomic dysfunction, Paranoia, Parkinsonism, Parkinsonism with favorable response to dopaminergic medication, Personality changes, Postural instability, Resting tremor, Rigidity, Schizophrenia, Scissor gait, Short stepped shuffling gait, Shuffling gait, Sleep disturbance, Slow saccadic eye movements, Spastic/hyperactive bladder, Spasticity, Substantia nigra gliosis, Talipes equinovarus, Tremor, Urinary urgency, Visual hallucinations, Weak voice, Weight loss

abnormal neuromuscular synapse morphology, abnormal respiratory electron transport chain, alpha-synuclein inclusion body, behavior/neurological phenotype, catalepsy, cellular phenotype, decreased dopamine level, decreased dopaminergic neuron number, decreased physiological sensitivity to xenobiotic, decreased susceptibility to bacterial infection, decreased susceptibility to dopaminergic neuron neurotoxicity, increased fasting circulating glucose level, increased mitochondrial size, increased physiological sensitivity to xenobiotic, long stride length, microgliosis, nervous system phenotype, no abnormal phenotype detected, premature death, reduced long term potentiation